Assessment of adherence with medications in human immunodeficiency virus-infected children

E Katko1, G M Johnson, S L Fowler

  • 1Department of Pediatrics Medical University of South Carolina Charleston, SC, USA.

Insights

Caregiver screening reliably predicts medication adherence in children with HIV. Nonadherence to appointments or inability to describe the regimen indicates poor adherence, impacting virologic response.

Area of Science:

  • Pediatric infectious diseases
  • HIV/AIDS management
  • Pharmacological adherence research

Background:

  • Medication adherence is critical for managing HIV infection in children.
  • Reliable screening tools are needed to identify children at risk of nonadherence.
  • Poor adherence can lead to treatment failure and disease progression.

Purpose of the Study:

  • To assess the reliability of caregiver screening for predicting medication adherence in pediatric HIV.
  • To identify specific caregiver-reported factors associated with medication nonadherence.
  • To evaluate the link between adherence levels and virologic outcomes.

Main Methods:

  • Cross-sectional study involving caregivers of HIV-infected children.
  • Screening questions focused on regimen understanding and appointment adherence.
  • Medication adherence assessed through caregiver reports and/or pharmacy refill data.
  • Virologic response defined by viral load suppression.

Main Results:

  • Caregivers unable to describe the medication regimen were significantly less likely to achieve adherence.
  • Nonadherence with scheduled appointments was a strong predictor of poor medication adherence.
  • Adherence to at least 90% of prescribed medication doses was associated with achieving a virologic response.

Conclusions:

  • Caregiver screening offers a reliable method for identifying potential nonadherence in pediatric HIV.
  • Targeted interventions for caregivers with poor regimen understanding or appointment adherence are warranted.
  • Improving medication adherence is essential for optimizing virologic outcomes in children with HIV.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...